Skip to main content
Fig. 5 | Gut Pathogens

Fig. 5

From: Production of highly immunogenic and safe Triton X-100 produced bacterial ghost vaccine against Shigella flexneri 2b serotype

Fig. 5

Serum bactericidal activity assay (SBA) of immunized and non-immunized challenged groups. A bar chart representing the serum bactericidal activity assay "SBA" calculated for all groups after 2 weeks of the last immunization dose The X-axis represents the tested groups (negative control “non-immunized non-challenged”, positive control “non-immunized challenged with S. flexneri 2b serotype ATCC 12022”, Sf-BGV/TW80 “immunized with S. flexneri bacterial ghost vaccine treated with (TW80) then challenged with S. flexneri 2b serotype ATCC 12022”, and Sf-BGV/TX100 “immunized with S. flexneri bacterial ghost vaccine treated with (TX100) then challenged with S. flexneri 2b serotype ATCC 12022”). The Y-axis represents the recorded SBA% for each group. (***) indicates a significant difference (P < 0.0001) compared to the positive control. The mean and standard deviation were obtained using one-way ANOVA data analysis

Back to article page

Gut Pathogens

ISSN: 1757-4749